Pharmacotherapeutic Update for Providers:
Microdosing Psychedelics
Tom Simpson, PharmD., RPh.
Discover the rapidly evolving field of psychedelic research, with ongoing clinical trials and studies exploring their safety and efficacy for various mental health conditions. However, it's important to emphasize that the use of psychedelics should always be conducted in controlled and supervised settings to minimize risks and maximize potential benefits. Instructor Tom Simpson, PharmD., RPh.
Fight the Fomites! COVID-19 Prevention and Management
Erik Gunderson, PharmD, BCPS, BCACP
It's essential to stay updated with the latest guidelines and recommendations from health authorities and consult with healthcare professionals to develop a patient-specific COVID-19 treatment plan, especially considering the evolving nature of the pandemic. Determining the appropriate COVID-19 treatment depends on several factors, including the patient's age, comorbidities, disease severity, and the presence of certain risk factors.
What the EF is Going on with Heart Failure?
Steven A. Elrod, PharmD, BCACP
The treatment of heart failure with reduced ejection fraction (HFrEF) has evolved over the years, and there are indeed some "new" foundational pillars that have become integral in managing this condition. These pillars are essential for improving patients' outcomes and enhancing their quality of life. Here are the "new" foundational pillars and an outline of outpatient setting treatment plans for HFrEF.
This event offers 2.6 contact hours to attendees and (2.6 Pharmacology c
Clock hours offered